Literature DB >> 10360332

Evaluation of a multidimensional measure of dyspepsia-related health for use in a randomized clinical trial.

K F Cook1, L Rabeneck, C J Campbell, N P Wray.   

Abstract

In previous work, we developed a multidimensional measure of dyspepsia-related health. To evaluate the adequacy of this instrument as an outcome measure for a large-scale, multicenter, randomized clinical trial, we used Rasch analysis to address three questions: (1) Are the scales interval-level? (2) Do the scales measure precisely across the entire range of dyspepsia outcomes? (3) Do the scales' items have an optimal number of response categories? We found that the scales were not interval-level and that they did not measure effectively at low or high levels of the dyspepsia-related outcomes. Our results also suggest that patients were capable of discriminating among only four- to seven-item response categories. Further studies are needed to identify items that effectively measure high and low levels of dyspepsia-related outcomes and to validate that decreasing the number of response categories improves the psychometric properties of these scales.

Entities:  

Mesh:

Year:  1999        PMID: 10360332     DOI: 10.1016/s0895-4356(99)00018-9

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  4 in total

1.  Patient-based assessment in dyspepsia: development and validation of Dyspepsia Symptom Severity Index (DSSI).

Authors:  N K Leidy; C Farup; A M Rentz; D Ganoczy; K L Koch
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

2.  Quality of life in patients with functional dyspepsia: Short- and long-term effect of Helicobacter pylori eradication with pantoprazole, amoxicillin, and clarithromycin or cisapride therapy: A prospective, parallel-group study.

Authors:  György M Buzás
Journal:  Curr Ther Res Clin Exp       Date:  2006-09

Review 3.  Symptom and health-related quality-of-life measures for use in selected gastrointestinal disease studies: a review and synthesis of the literature.

Authors:  A M Rentz; C Battista; E Trudeau; R Jones; P Robinson; S Sloan; S Mathur; L Frank; D A Revicki
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

4.  A Rasch and factor analysis of the Functional Assessment of Cancer Therapy-General (FACT-G).

Authors:  Adam B Smith; Penny Wright; Peter J Selby; Galina Velikova
Journal:  Health Qual Life Outcomes       Date:  2007-04-20       Impact factor: 3.186

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.